AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 161 min read$YDES

Shen Ethan PhD purchased $49K of YDES

Shen Ethan PhD (CEO) purchased 12,700 shares of YD Bio Ltd (YDES) at $3.85 on 2026-09-14.

Original reporting
SEC EDGAR · Shen Ethan PhD
Published Sep 16, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$YDES
Neutral
medium confidence
Mentioned
$YDES
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$YDESNeutralLow
01

Why it matters

The disclosed purchase is modest and unlikely to affect market perception of YD Bio Ltd.

02

Market read

Routine insider purchase with limited trading relevance.

03

What to watch

Potential future insider activity if the CEO continues to accumulate shares.

Relevance 4/10Novelty 3/10Timing: filed 2026-09-16

Background

Form 4 filings disclose insider trades; investors monitor them for signals of confidence or concern.

Company-level read

Ticker impact

$YDESNeutralMedium confidence
Context

CEO Shen Ethan purchased 12,700 shares for $48,895, increasing his stake to over 11 million shares.

Expected impact

Minimal short‑term impact; unlikely to move the stock materially.

Evidence & confidence

The transaction amount is under $50k, typical for routine 10b5‑1 plans, and does not represent a material shift in ownership.

Market effects

Sector

None; the biotech sector is unaffected by a micro‑insider purchase.

Regional

No regional effect; the filing is specific to YD Bio Ltd.

Global

Low; isolated insider transaction.

Counterpoint

What could challenge this read

The purchase could be a signal of upcoming positive news, but the amount is too small to be meaningful.

Key entities

  • person
    Shen Ethan PhD

    CEO of YD Bio Ltd.

  • company
    YD Bio Ltd

    Biotech firm listed under ticker YDES.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

YDES insider trading history →

Related articles

AUG 31
$YDESMed

YD Bio Ltd (YDES): Financial results for H1 2026

YD Bio Ltd (YDES) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026 TAIPEI, Taiwan, Aug. 31, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detec

SEC EDGAR 6-K2 min
JUL 7
$LUCYMedAI 8/10

Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update

Biotech gainers: Innovative Eyewear (LUCY) rose 63% after preliminary Q2 2026 net sales of ~$0.99M (+71% YoY) and new retail orders; Seer (SEER) jumped 35% on an unsolicited $2.45/share cash takeover proposal plus contingent value rights; Orthofix (OFIX) and Enovis (ENOV) gained 16%/15% after CMS withdrew reimbursement changes for non-invasive bone growth stimulators.

rttnews.com6 min
SEP 17
$DELLLow

Silver Lake Partners V DE (AIV), L.P. (Durban Egon) sold $14.9M of DELL (indirect holdings)

Silver Lake Partners V DE (AIV), L.P. sold 26,990 indirectly-held shares of Dell Technologies Inc. (DELL) at an average of $552.79 ($542.78–$564.46, $14.92M total) across 22 trades on 2026-09-15. Filed jointly with Silver Lake Technology Associates V, L.P. (Director), SLTA V (GP), L.L.C. (Director), Silver Lake Group, L.L.C. (Director) and Durban Egon (Director).

SEC EDGAR1 min